Details for New Drug Application (NDA): 019451
✉ Email this page to a colleague
The generic ingredient in LOPRESSIDONE is chlorthalidone; metoprolol tartrate. There are twenty-one drug master file entries for this compound. Additional details are available on the chlorthalidone; metoprolol tartrate profile page.
Summary for 019451
Tradename: | LOPRESSIDONE |
Applicant: | Novartis |
Ingredient: | chlorthalidone; metoprolol tartrate |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG;100MG | ||||
Approval Date: | Dec 31, 1987 | TE: | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CAPSULE;ORAL | Strength | 25MG;200MG | ||||
Approval Date: | Dec 31, 1987 | TE: | RLD: | No |
Expired US Patents for NDA 019451
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-001 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
Novartis | LOPRESSIDONE | chlorthalidone; metoprolol tartrate | CAPSULE;ORAL | 019451-002 | Dec 31, 1987 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Complete Access Available with Subscription